In anatomic pathology, immunohistochemistry (IHC) serves as a diagnostic and prognostic method for identification of disease markers in tissue samples that directly influences classification and grading the disease, influencing patient management. However, till today over most of the world, pathological analysis of tissue samples remained a time-consuming and subjective procedure, wherein the intensity of antibody staining is manually judged and thus scoring decision is directly influenced by visual bias. This instigated us to design a simple method of automated digital IHC image analysis algorithm for an unbiased, quantitative assessment of antibody staining intensity in tissue sections. As a first step, we adopted the spectral deconvolution method of DAB/hematoxylin color spectra by using optimized optical density vectors of the color deconvolution plugin for proper separation of the DAB color spectra. Then the DAB stained image is displayed in a new window wherein it undergoes pixel-by-pixel analysis, and displays the full profile along with its scoring decision. Based on the mathematical formula conceptualized, the algorithm is thoroughly tested by analyzing scores assigned to thousands (n = 1703) of DAB stained IHC images including sample images taken from human protein atlas web resource. The IHC Profiler plugin developed is compatible with the open resource digital image analysis software, ImageJ, which creates a pixel-by-pixel analysis profile of a digital IHC image and further assigns a score in a four tier system. A comparison study between manual pathological analysis and IHC Profiler resolved in a match of 88.6% (P<0.0001, CI = 95%). This new tool developed for clinical histopathological sample analysis can be adopted globally for scoring most protein targets where the marker protein expression is of cytoplasmic and/or nuclear type. We foresee that this method will minimize the problem of inter-observer variations across labs and further help in worldwide patient stratification potentially benefitting various multinational clinical trial initiatives.
References
[1]
Ruifrok AC, Johnston DA (2001) Quantification of histochemical staining by color deconvolution. Anal Quant Cytol Histol 23: 291–299.
[2]
McCarty KS Jr, Szabo E, Flowers JL, Cox EB, Leight GS, et al. (1986) Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors. Cancer Res 46: 4244s–4248s.
[3]
Harvey JM, Clark GM, Osborne CK, Allred DC (1999) Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer. J Clinical Oncology 17: 1474–1481.
[4]
Hsu SM, Raine L, Fanger H (1981) Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. Journal of Histochemistry & Cytochemistry 29: 577–580. doi: 10.1177/29.4.6166661
[5]
Choudhury KR, Yagle KJ, Swanson PE, Krohn KA, Rajendran JG (2010) A Robust Automated Measure of Average Antibody Staining in Immunohistochemistry Images. J Histochem Cytochem 58: 95–107. doi: 10.1369/jhc.2009.953554
[6]
Yukako Yagi, Gilbertson JR (2005) Digital imaging in pathology: the case for standardization. Journal of Telemedicine and Telecare 11: 109–116.
[7]
Brey EM, Lalani Z, Johnston C, Wong M, McIntire LV, et al. (2003) Automated Selection of DAB-labeled Tissue for Immunohistochemical Quantification. J Histochem Cytochem 51: 575–584. doi: 10.1177/002215540305100503
[8]
Konsti J, Lundin M, Joensuu H, Lehtimaki T, Sihto H, et al. (2011) Development and evaluation of a virtual microscopy application for automated assessment of Ki-67 expression in breast cancer. BMC Clinical Pathology 11: 1–11. doi: 10.1186/1472-6890-11-3
[9]
Vrekoussis T, Chaniotis V, Navrozoglou I, Dousias V, Pavlakis K, et al. (2009) Image Analysis of Breast Cancer Immunohistochemistry-stained Sections Using ImageJ – An RGB-based Model. Anticancer Research 29: 4995–4998.
[10]
Matkowskyj KA, Schonfeld D, Benya RV (2000) Quantitative Immunohistochemistry by Measuring Cumulative Signal Strength Using Commercially Available Software Photoshop and Matlab. Journal of Histochemistry & Cytochemistry 48: 303–311. doi: 10.1177/002215540004800216
[11]
Tuominen VJ, Ruotoistenmaki S, Viitanen A, Jumppanen M, Isola J (2010) ImmunoRatio: a publicly available web application for quantitative image analysis of estrogen receptor (ER), progesterone receptor (PR), and Ki-67. Breast Cancer Res 12: R56. doi: 10.1186/bcr2615
[12]
Wenbin Ma, Lozanoff S (1998) A Full Color System for Quantitative Assessment of Histochemical and Immunohistochemical Staining Patterns. Biotechnic & Histochemistry 74: 1–9. doi: 10.3109/10520299909066470
[13]
Pham NA, Morrison A, Schwock J, Aviel-Ronen S, Iakovlev V, et al. (2007) Quantitative image analysis of immunohistochemical stains using a CMYK color model. Diagn Pathol 2: 8.
[14]
Prasad K, Tiwari A, Ilanthodi S, Prabhu G, Pai M (2011) Automation of immunohistochemical evaluation in breast cancer using image analysis. World J Clin Oncol 2: 187–194.
[15]
Rangan GK, Tesch GH (2007) Quantification of renal pathology by image analysis. Nephrology (Carlton) 12: 553–558. doi: 10.1111/j.1440-1797.2007.00855.x
[16]
Dobson L, Conway C, Hanley A, Johnson A, Costello S, et al. (2010) Image analysis as an adjunct to manual HER-2 immunohistochemical review: a diagnostic tool to standardize interpretation. Histopathology 57: 27–38. doi: 10.1111/j.1365-2559.2010.03577.x
[17]
Rexhepaj E, Brennan DJ, Holloway P, Kay EW, McCann AH, et al. (2008) Novel image analysis approach for quantifying expression of nuclear proteins assessed by immunohistochemistry: application to measurement of oestrogen and progesterone receptor levels in breast cancer. Breast Cancer Res 10: R89. doi: 10.1186/bcr2187
[18]
Kampf C, Bergman J, Oksvold P, Asplund A, Navani S, et al. (2012) A tool to facilitate clinical biomarker studies – a tissue dictionary based on the Human Protein Atlas. BMC Med 10: 103. doi: 10.1186/1741-7015-10-103
[19]
Ponten F, Gry M, Fagerberg L, Lundberg E, Asplund A, et al. (2009) A global view of protein expression in human cells, tissues, and organs. Mol Syst Biol 5: 337. doi: 10.1038/msb.2009.93
[20]
J？hne B (1997) Practical handbook on image processing for scientific applications. Boca Raton, Florida: CRC Press. 76–82 p.
[21]
Chatterjee S, Malhotra R, Varghese F, Bukhari AB, Patil A, et al. (2013) Quantitative Immunohistochemical Analysis Reveals Association between Sodium Iodide Symporter and Estrogen Receptor Expression in Breast Cancer. PLOS ONE 8.
[22]
Schneider CA, Rasband WS, Eliceiri KW (2012) NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9: 671–675. doi: 10.1038/nmeth.2089
[23]
Jaraj SJ, Camparo P, Boyle H, Germain F, Nilsson B, et al. (2009) Intra- and interobserver reproducibility of interpretation of immunohistochemical stains of prostate cancer. Virchows Arch 455: 375–381. doi: 10.1007/s00428-009-0833-8
[24]
Gavrielides MA, Gallas BD, Lenz P, Badano A, Hewitt SM (2011) Observer Variability in the Interpretation of HER2/neu Immunohistochemical Expression With Unaided and Computer-Aided Digital Microscopy. Arch Pathol Lab Med 135: 233–242.
[25]
Ruifrok AC, Katz RL, Johnston DA (2003) Comparison of Quantification of Histochemical Staining By Hue-Saturation-Intensity (HSI) Transformation and Color-Deconvolution. Appl Immunohistochem Mol Morphol 11: 85–91. doi: 10.1097/00129039-200303000-00014
[26]
Turbin DA, Leung S, Cheang MC, Kennecke HA, Montgomery KD, et al. (2008) Automated quantitative analysis of estrogen receptor expression in breast carcinoma does not differ from expert pathologist scoring: a tissue microarray study of 3,484 cases. Breast Cancer Res Treat 110: 417–426. doi: 10.1007/s10549-007-9736-z
[27]
Gokhale S, Rosen D, Sneige N, Diaz LK, Resetkova E, et al. (2007) Assessment of two automated imaging systems in evaluating estrogen receptor status in breast carcinoma. Appl Immunohistochem Mol Morphol 15: 451–455. doi: 10.1097/pai.0b013e31802ee998
[28]
Ellis CM, Dyson MJ, Stephenson TJ, Maltby EL (2005) HER2 amplification status in breast cancer: a comparison between immunohistochemical staining and fluorescence in situ hybridisation using manual and automated quantitative image analysis scoring techniques. J Clin Pathol 58: 710–714. doi: 10.1136/jcp.2004.023424
[29]
Chung GG, Zerkowski MP, Ghosh S, Camp RL, Rimm DL (2007) Quantitative analysis of estrogen receptor heterogeneity in breast cancer. Lab Invest 87: 662–669. doi: 10.1038/labinvest.3700543
